Sales and Marketing

Showing 15 posts of 11526 posts found.

stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
astrazeneca_plaque

AstraZeneca jettisons European heart drug rights for $210m

July 24, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

FDA approves Agios’ oral leukaemia treatment Tibsovo

July 23, 2018 Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018 Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
roche_dark_0

Roche join Pfizer and others in price freeze while critics pose questions

July 23, 2018 Sales and Marketing Donald Trump, Roche, generics, price freezes

Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …
fda2outsideweb

FDA approves Pfizer biosimilar version of Amgen’s Neupogen

July 23, 2018 Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma

The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …
li_keqiang_chinese_and_foreign_press_conference

Chinese premier slams drug maker after vaccine scandal

July 23, 2018 Sales and Marketing CCP, China, biotech, scandal, vaccines

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

Novartis buys eczema drug in €95m deal

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …

PhRMA take on PBM’s in response to Trump drug price plan

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …
28246711066_52e38bc591_z

MPs vote to stay in EMA after Brexit

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
janssen_latest_logo_on_sign

Janssen’s Symtuza scores approval with the FDA in HIV-1

July 18, 2018 Sales and Marketing HIV, Janssen, Symtuza, pharma

Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …
shutterstock_138095450

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018 Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …
The Gateway to Local Adoption Series

Latest content